Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | RBP4 | P02753 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL164232 | 0.80 | L3MBTL1 (0.58) | ALDH1A1PKML3MBTL1GAASMN1; SMN2 | |
| SCHEMBL13589980 | 0.80 | L3MBTL1 (0.58) | ALDH1A1PKML3MBTL1GAASMN1; SMN2 | |
| SCHEMBL14493665 | 0.80 | L3MBTL1 (0.58) | ALDH1A1PKML3MBTL1GAASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL1061966 | 0.78 | L3MBTL1 (0.61) | ALDH1A1PKML3MBTL1GAASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL4712253 | 0.78 | L3MBTL1 (0.61) | ALDH1A1PKML3MBTL1GAASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL4712251 | 0.78 | L3MBTL1 (0.61) | ALDH1A1PKML3MBTL1GAASMN1; SMN2 | |
| SCHEMBL5486305 | 0.78 | L3MBTL1 (0.56) | ALDH1A1PKML3MBTL1GAASMN1; SMN2 | |
| SCHEMBL5193831 | 0.75 | PKM (0.45) | ALDH1A1PKMGAAHSD11B1 | |
| SCHEMBL15249744 | 0.75 | TSHR (0.43) | GAALMNATHRB | |
| SCHEMBL2746270 | 0.74 | L3MBTL1 (0.53) | ALDH1A1PKML3MBTL1GAASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1188743-B1 | PROCESS FOR PREPARING ORGANIC SULFUR ACIDS OR SALTS THEREOF | DAICEL CHEM (JP) | 2009-06-17 | — | — | EP | disclosed |
| US-6706915-B2 | USING A METAL COMPOUND AS A CATALYST, A CORRESPONDING ORGANIC SULFONIC ACID OR A SALT CAN BE OBTAINED BY REACTING AN ORGANIC SUBSTRATE WITH A SULFUR OXIDE IN THE ABSENCE OF N-HYDROXY AND N-OXO CYCLIC IMIDE COMPOUNDS | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2004-03-16 | — | — | US | disclosed |
| US-20020161255-A1 | Process for preparing organic sulfur acids or salts thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2002-10-31 | — | — | US | disclosed |
| EP-1188743-A1 | PROCESS FOR PREPARING ORGANIC SULFUR ACIDS OR SALTS THEREOF | Daicel Chemical Industries, Ltd. (JP) | 2002-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020161255-A1 | Process for preparing organic sulfur acids or salts thereof | BHMT2, TST, ICMT | ALDH1A1 1968/4885PKM 3053/4885L3MBTL1 4197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.